»
Antikörper
»
anti-MutL Homolog 1, Colon Cancer, Nonpolyposis Type 2 (E. Coli) (MLH1) Antikörper
MutL Homolog 1, Colon Cancer, Nonpolyposis Type 2 (E. Coli) (MLH1) Antikörper
| Antigen |
|
| Synonyme |
FCC2, COCA2, HNPCC, hMLH1, HNPCC2, MGC5172, MGC66301, zgc:66301, MLH1, MGC140127, LOC100232198 |
| Klonalität |
Polyklonal |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
 Alternativen Immunhistochemie (Gefrierschnitte) (IHC (fro)), Immunpräzipitation (IP), Western Blot (WB)
Western Blot (WB) (30), Immunhistochemie (Paraffinschnitte) (IHC (p)) (22), Immunfluoreszenz (IF) (11), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (8), Immunpräzipitation (IP) (7), ELISA (6), Immunzytochemie (ICC) (3), Immunhistochemie (IHC) (3), Enzyme Immunoassay (EIA) (2), Durchflusszytometrie (FACS) (2), Dot Blot (Dot) (1)
|
| Produktnummer |
ABIN151469 |
| Menge |
0.1 mg (1 mg/ml) (Varianten) |
| Preis |
410,00 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 7 bis 10 Werktagen |
|
Weitere Bezeichnung
|
MLH1
|
|
Gen-ID
|
4292
|
|
Swiss-Prot
|
NP_0002401
|
|
Immunogen
|
The epitope recognized by this antibody maps to a region between residue 700 and theC-terminus (residue 756) of human mutL homolog 1 using the numbering given in entryNP_000240.1 (GeneID 4292).
|
|
Beschreibung
|
MLH1 is a DNA mismatch repair gene, mutations in MLH1 are implicated in hereditarynonpolyposis colorectal cancer (HNPCC). Alternate Names: anti-COCA2 antibody, anti-FCC2 antibody, anti-HNPCC antibody, anti-HNPCC2antibody, anti-MGC5172 antibody, anti-hMLH1 antibody. Related Diseases: HNPCC
|
|
Spezifität
|
ABIN151469 reacts with MLH1. Species Reactivity: Human.
|
|
Applikationshinweise
|
Suggested working dilutions: immunohistochemistry 1:50-1:200,immunoprecipitation 1-4 ul,Western Blot 1:500-1:5000
|
|
Konzentration
|
1 mg/ml
|
|
Buffer
|
Tris-citrate/phosphate buffer, pH 7 to 8. Preservative: 0.09% Sodium Azide.
|
|
Lagerung
|
Store at 4C. Do not freeze.
|
|
Forschungsgebiet
|
Krebs, DNS/RNS
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
Shen, Hu, Jeng et al.: "Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival." in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, Issue 2, pp. 417-23, 2009 (PubMed).
|
Alternativen zu Antigen "MutL Homolog 1, Colon Cancer, Nonpolyposis Type 2 (E. Coli) (MLH1)", Typ "Antikörper" finden
|
Wirte
|
Kaninchen (31), Maus (20)
|
|
Reaktivitäten
|
Human (45), Ratte (Rattus) (11), Maus (7), Hamster (3), Huhn (1), Hund (1), Fruchtfliege (Drosophila melanogaster) (1), Affe (1), Schwein (1), Primate (1)
|
|
Applikationen
|
Western Blot (WB) (30), Immunhistochemie (Paraffinschnitte) (IHC (p)) (22), Immunfluoreszenz (IF) (11), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (8), Immunpräzipitation (IP) (7), ELISA (6), Immunzytochemie (ICC) (3), Immunhistochemie (IHC) (3), Enzyme Immunoassay (EIA) (2), Durchflusszytometrie (FACS) (2), Dot Blot (Dot) (1)
|
|
Konjugate
|
Agarose Beads (1)
|
